|Bid||0.008 x 0|
|Ask||0.009 x 0|
|Day's range||0.0080 - 0.0080|
|52-week range||0.0080 - 0.0210|
|Beta (3Y monthly)||1.82|
|PE ratio (TTM)||N/A|
|Earnings date||1 Mar. 2016 - 5 Mar. 2016|
|Forward dividend & yield||N/A (N/A)|
|1y target est||0.25|
MELBOURNE, Australia, Sept. 17, 2018-- Hainan Resort Software Community has on behalf of Hainan Ecological Smart City Group formally extended an invitation to Genetic Technologies Limited to establish ...
Today, Genetic Technologies (GENE) was trading over 70% higher than yesterday’s closing price of $1.09. The stock jumped ~72.5% in premarket trading. The stock price and volumes rose on the news of the company’s on-track breast cancer and colorectal cancer risk assessment tests, slated for release in October.